For everyone else, the evidence favors tirzepatide
10.1038/cddis.2017.28 Summary Keywords GLP-1, oral delivery, vagal afferents, diabetes, obesity, peptide Citation New RRC, Bogus M, Travers GN, Hahn U, Vaiceliunaite A, Burnet M, Wang JH and Wen H (2024) Glucagon-like peptide-1 receptor agonists for treatment of diabetes and obesity: advantage of oral delivery
Osteoarthritis Cartilage 2003;11:783-9
Most side effects occur during the first few months of treatment and typically decrease over time as your body adjusts to the medication
For instance, quitting smoking and reducing alcohol consumption can benefit overall health and may improve the bodys ability to absorb and utilize vitamin B12
However, scientific research on these purported benefits is limited and mixed